EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Advancing Tuberculosis Chemotherapy: Targeted Nanomedicines for the Mycobacterium TB Granuloma

Shreya Ranjith Singh iD, Maya Mellisa Makatini iD, Thashree Marimuthu iD, Yahya Essop Choonara iD

Small · 2025-12 · 21 (49)

DOI: 10.1002/smll.202506381 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Small, online erschienen am 30.10.2025. Verfasst von Shreya Ranjith Singh und 3 weiteren Autor:innen. Beteiligte Einrichtung: Wits Advanced Drug Delivery Platform Research Unit, Department of Pharmacy and Pharmacology, School of Therapeutic Sciences, Faculty of Health Scienc…. Hauptthemen laut MEDLINE: Granuloma, Nanomedicine, Tuberculosis, Mycobacterium tuberculosis. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 193 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This review examines the potential of nanosystems for targeted tuberculosis (TB) therapy, focusing on biodegradable polymeric, lipid‐based, extracellular vesicles, and selected inorganic nanocarriers engineered to deliver anti‐TB drugs directly to granulomas, the hallmark of TB pathology. Both passive and active targeting strategies are discussed, emphasizing how these approaches enhance drug accumulation at infection sites to curb disease progression. Preclinical studies, including laboratory and animal models, are reviewed to assess their therapeutic impact. Although the results are promising, hurdles such as biocompatibility, regulatory constraints, and optimizing drug release still pose challenges for clinical implementation. However, rationally designed nanosystems hold significant potential for improving TB treatment outcomes. Further research is crucial for refining nanocarrier design and addressing translational hurdles. Future directions include integrating nanosystems with advanced molecular imprinting technologies (MIT) and molecularly imprinted polymer nanoparticles (MIPNPs) for enhanced granuloma targeting and controlled drug release. Additionally, immunotherapy and gene therapy offer novel adjunct strategies to boost host immunity and deliver targeted genetic interventions. These emerging approaches, combined with optimized nanosystems, have the potential to revolutionize TB management by improving drug delivery, reducing treatment duration, and enhancing therapeutic outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GranulomaNanomedicineTuberculosisMycobacterium tuberculosisAntitubercular AgentsHumansAnimalsNanoparticlesDrug Delivery Systems

Stichwörter der Autor:innen

drug deliverygranulomananosystemstargeted drug deliverytuberculosis

Substanzen

Antitubercular Agents

Autor:innen und Institutionen

  • Wits Advanced Drug Delivery Platform Research Unit, Department of Pharmacy and Pharmacology, School of Therapeutic Sciences, Faculty of Health Sciences, University of the Witwatersrand, 7 York Road Parktown, Johannesbur…
  • Molecular Sciences Institute, School of Chemistry, University of the Witwatersrand, Private Bag 3, PO WITS, 2050, South Africa.
  • Wits Infectious Diseases and Oncology Research Institute, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.

ORCID-Profile: Shreya Ranjith Singh, Maya Mellisa Makatini, Thashree Marimuthu, Yahya Essop Choonara

Förderung

  • National Research Foundation

Zitieren

APA

Ranjith Singh, S., Makatini, M. M., Marimuthu, T., & Choonara, Y. E. (2025). Advancing Tuberculosis Chemotherapy: Targeted Nanomedicines for the Mycobacterium TB Granuloma. Small, 21(49). https://doi.org/10.1002/smll.202506381

Vancouver

Ranjith Singh S, Makatini MM, Marimuthu T, Choonara YE. Advancing Tuberculosis Chemotherapy: Targeted Nanomedicines for the Mycobacterium TB Granuloma. Small. 2025;21(49). doi:10.1002/smll.202506381

BibTeX
@article{RanjithSingh2025,
  author = {Ranjith Singh, Shreya and Makatini, Maya Mellisa and Marimuthu, Thashree and Choonara, Yahya Essop},
  title = {Advancing Tuberculosis Chemotherapy: Targeted Nanomedicines for the Mycobacterium TB Granuloma},
  journal = {Small},
  year = {2025},
  volume = {21},
  number = {49},
  doi = {10.1002/smll.202506381}
}
Kostenlos starten →